New active paclitaxel glucuronide derivative with improved water solubility

International Journal of Oncology

Volumn 12, Issue 2, 1998, Pages 391-394

  Paradis, Renée ^a   Pagé, Michel ^a  

^a UNIVERSITÉ LAVAL   (Canada)

Author keywords

Chemotherapy; Paclitaxel; Taxol

Indexed keywords

PACLITAXEL DERIVATIVE; PACLITAXEL GLUCURONIDE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CONFORMATIONAL TRANSITION; DRUG CONFORMATION; DRUG SOLUBILITY; DRUG SYNTHESIS; FEMALE; HUMAN; HUMAN CELL; OVARY CARCINOMA; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION; TERATOCARCINOMA;

EID: 0031909425     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.12.2.391     Document Type: Article

References (36)

1. Rowinsky EK, Cazenave LA and Donehower RC: Taxol: a novel investigational antimicrotubule agent. J Natl Cancer Inst 82: 1247-1259, 1990.
2. Suffness M: Taxol: from discovery to therapeutic use. In: Annual Reports in Medicinal Chemistry. Academic Press, Inc., pp305-314, 1993.
3. Wani MC, Taylor HL, Wali ME, Coggon P and McPhail AT: Plant antitumor agents. VI. The isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifolia. J Am Chem Soc 93: 2325-2327, 1971.
4. Kumar N: Taxol induced polymerization of purified tubulin. Mechanism of action. J Biol Chem 256: 10435-10441, 1981.
5. Thompson WC, Wilson L and Punch DL: Taxol induces microtubule assembly at low temperature. Cell Motil 1: 445-454, 1981.
6. Schiff PB, Fant J and Horwitz SB: Promotion of microtubules assembly in vitro by taxol. Nature 277: 665-667, 1979.
7. Schiff PB and Horwitz SB: Taxol stabilizes microtubules in mouse fibroblast cells. Proc Natl Acad Sci USA 77: 1561-1565, 1980.
8. Schiff PB and Horwitz SB: Taxol assembles tubulin in the absence of exogenous guanosine 5'-triphosphate of microtubule-associated proteins. Biochemistry 20: 3247-3252, 1981.
9. Marth C, Lang T, Widschwendter M, Muller-Holzner E and Daxenbichler G: Effects of taxol on choriocarcinoma cells. Am J Obstet Gynecol 173: 1835-1842, 1995.
10. Saunders DE, Lawrence WD, Christensen C, Wappler NL, Ruan H and Deppe G: Paclitaxel-induced apoptosis in MCF-7 breast-cancer cells. Int J Cancer 70: 214-220, 1997.
11. Fallo F, Pilon C, Barzon L, Pistorella M, Pagotto U, Altavilla G, Boscaro M and Sonino N: Effects of taxol on the human NCI-H295 adrenocortical carcinoma cell line. Endocr Res 22: 709-715, 1996.
12. Manfredi JJ, Parness J and Horwitz SB: Taxol binds to cellular microtubules. J Cell Biol 94: 688-696, 1982.
13. Marty M, Extra JM, Culine S and Rousseau F: Taxol et adénocarcinomes ovariens. Pathol Biol 39: 834-835, 1991.
14. Jacrot M, Riondel J, Picot F, Leroux D, Mouriquand C, Beriel H and Potier P: Action of taxol on human tumors transplanted in athymic mice. C.R. Seances Acad Sci III 297: 597-600, 1983.
15. Holmes FA, Walters RS, Theriault RL, Forman AD, Newton LK, Raber MN, Buzdar AU, Frye DK and Hortobagyi GN: Phase II trial of taxol, an active drug in the treatment of metastatic breast cancer. J Natl Cancer Inst 83: 1797-1805, 1991.
16. Wiernik PH, Schwartz EL, Strauman JJ, Dutcher JP and Lipton RB: Phase I clinical and pharmacokinetic study of taxol. Cancer Res 47: 2486-2493, 1987.
17. McGuire WP, Rowinsky EK, Rosenshein NB, Grumbine FC, Ettinger DS, Armstrong DK and Donehower RC: Taxol: a unique antineoplastic agent with significant activity in advanced ovarian epithelial neoplasms. Ann Int Med 111: 273-279, 1989.
18. Markman M: Taxol: an important new drug in the management of epithelial ovarian cancer. Yale J Biol Med 64: 583-590, 1991.
19. Einzig AI, Wiernik PH and Schwartz EL: Taxol: a new agent active in melanoma and ovarian cancer. Cancer Treat Res 58: 89-100, 1991.
20. Einzig AI, Wiernik PH, Sasloff J, Runowicz CD and Goldberg GL: Phase II study and long-term follow-up of patients treated with taxol for advanced ovarian adenocarcinoma. J Clin Oncol 10: 1748-1753, 1992.
21. Weiss RB, Donehower RC, Wiernik PH, Ohnuma T, Gralla RJ, Trump DL, Baker JR Jr, van-Echo DA, von-Hoff DD and Leyland-Jones B: Hypersensitivity reactions from taxol. J Clin Oncol 8: 1263-1268, 1990.
22. Mathew AE, Mejillano MR, Nath JP, Himes RH and Stella VJ: Synthesis and evaluation of some water-soluble prodrugs and derivatives of taxol with antitumor activity. J Med Chem 35: 145-151, 1992.
23. Deutsch HM, Glinski JA, Hernandez M, Haugwitz RD, Narayanan VL, Suffness M and Zalkow LH: Synthesis of congeners and prodrugs 3. Water-soluble prodrugs of taxol with potent antitumor activity. J Med Chem 32: 788-792, 1989.
24. Kingston DGI: The chemistry of taxol. Pharmac Ther 52: 1-34, 1991.
25. Parness J, Kingston DGI, Powell RG, Harracksingh C and Horwitz SB: Structure-activity study of cytotoxicity and microtubule assembly in vitro by taxol and related taxanes. Biochem Biophys Res Comm 105: 1082-1089, 1982.
26. Magri NF and Kingston DGI: Modified Taxols 4. Synthesis and biological activity of taxols modified in the side chain. J Nat Prod 51: 298-306, 1988.
27. Zhao Z and Kingston KGI: Modified taxols 6. Preparation of water-soluble prodrugs of taxol. J Nat Prod 54: 1607-1611, 1991.
28. Guéritte-Voegelein F, Guénard D, Lavelle F, le Goff M-T, Mangatal L and Potier P: Relationships between the structure of taxol analogues and their antimitotic activity. J Med Chem 34: 992-998, 1991.
29. Lataste H, Sénilh V, Wright M, Guénard D and Potier P: Relationships between the structure of taxol and baccatin III derivatives and their in vitro action on the disassembly of mammalian brain and Physarum amoebal microtubules. Proc Am Ass Cancer Res 81: 4090-4094, 1984.
30. Bollenbach GN, Long JW, Benjamin DG and Lindquist JA: The synthesis of Aryl-D-glucopyranosiduronic acids. J Am Chem Soc 77: 3310-3315, 1954.
31. Turgeon J, Paré J, Lalande M, Grech-Bélanger O and Bélanger PM: Isolation and structural characterization by spectroscopic methods of two glucuronide metabolites of mexiletine after N-oxidation and deamination. Drug Metab Disp 20: 762-769, 1992.
32. Banaszek A, Krowicki K and Zamojski A: Thin layer and column chromatography of erythromycins and some degradation products. J Chromatogr 32: 581-583, 1968.
33. Smith I: Sugars and related compounds. In: Chromatographic and Electrophoretic Techniques. New York, Interscience Publishers Inc., p251, 1960.
34. Page B, Page M and Noël C: A new fluorometric assay for cytotoxicity measurements in vitro. Int J Oncol 3: 473-476, 1993.
35. Kingston DGI, Samaranayake G and Ivey CA: The chemistry of taxol, a clinically useful anticancer agent. J Nat Prod 53: 1-12, 1990.
36. Scott RM: Amino acids. In: Clinical Analysis by Thin-layer Chromatography Techniques. Humphrey Science Publishers, Inc., Ann Arbor, pp86-87, 1969.